Ligand Pharmaceuticals Incorporated (LGND) Earnings Per Share (EPS)
Ligand Pharmaceuticals Incorporated (LGND) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | $20.67 |
| 2020-12-31 | -$0.11 |
| 2021-12-31 | $2.15 |
| 2022-12-31 | -$1.98 |
| 2023-12-31 | $3.02 |
| 2024-12-31 | -$1.64 |
| 2025-12-31 | $6.44 |
How LGND compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| HAE | Haemonetics Corporation | $2.05 |
| ARWR | Arrowhead Pharmaceuticals Inc. | -$0.01 |
| HROW | Harrow Inc Com | -$0.14 |
| RDNT | RadNet Inc. | -$0.25 |
| ARVN | Arvinas Inc. | -$1.14 |
These are five companies in the same sector as LGND with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("LGND")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LGND | $294.60 | +0.00% | 0.26M |
| 3 | ||||
| 4 | ||||
| 5 |